|
|||||
|
|
Leveraging the attributes of biologics and small molecules,and releasing the bottlenecks: a new wave of revolution in drug development |
|
| Authors: | Charles Oo Suraj S. Kalbag |
| Affiliation: | 1. SunLife Biopharma, Morris Plains, NJ, USAcharlesoo@yahoo.com;3. Neikalus Communications, Waldwick, NJ, USA |
| Abstract: | |
| Keywords: | Biologics small molecules proteins antibody-drug conjugates peptides monoclonal antibodies lymphatic circulation drug development receptor-mediated drug disposition antibody fragments |